Jounce Therapeutics, Inc. is #96 in rating Stock price grown in a week on NGM. Jounce Therapeutics, Inc. is #153 in rating Stock price grown in 3 years on NGM. Jounce Therapeutics, Inc. is #172 in rating Stock price grown in 3 months on NGM. Jounce Therapeutics, Inc. is #199 in rating Capitalization on NGM.
Jounce Therapeutics, Inc. earnings per share rating is determined in each financial period. Earnings per share - an indicator calculated by the formula: all the company's profit for the reporting period by the number of shares in the company. The “earnings per share” rating is higher if the company's earnings per share are greater.
Rating Jounce Therapeutics, Inc. net income - a rating compiled by the total amount of the company's income for the reporting financial period. The company's income or profit for the Net Income rating does not consider the total number of shares of the company and their value. The top ranking of "Net income of the company" is usually headed by the largest and most profitable companies.
|